Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer
Abstract Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to, increased expression of the CTLA-4 and...
Main Authors: | Jacob J. Adashek, Pedro Nazareth Aguiar Junior, Natalie Galanina, Razelle Kurzrock |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-05-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0618-9 |
Similar Items
-
Premature clinical trial discontinuation in the era of immune checkpoint inhibitors
by: Khunger, Monica, et al.
Published: (2018) -
Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors
by: Guoqiang PAN, et al.
Published: (2019-12-01) -
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2020-07-01) -
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
by: Raphael Mohr, et al.
Published: (2021-03-01) -
Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)